vs

Side-by-side financial comparison of ALCON INC (ALC) and National Vision Holdings, Inc. (EYE). Click either name above to swap in a different company.

ALCON INC is the larger business by last-quarter revenue ($2.6B vs $487.3M, roughly 5.3× National Vision Holdings, Inc.). ALCON INC runs the higher net margin — 6.8% vs 0.7%, a 6.1% gap on every dollar of revenue. On growth, National Vision Holdings, Inc. posted the faster year-over-year revenue change (7.9% vs 4.0%).

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.

Vision Research is an international company that manufactures high-speed digital cameras based in Wayne, New Jersey. Their cameras are marketed under the Phantom brand, and are used in a broad variety of industries including: defense, industrial product development, manufacturing, automotive, scientific research, and entertainment. Vision Research is a business unit of the Materials Analysis Division of Ametek Inc., a global manufacturer of electronic instruments and electromechanical devices.

ALC vs EYE — Head-to-Head

Bigger by revenue
ALC
ALC
5.3× larger
ALC
$2.6B
$487.3M
EYE
Growing faster (revenue YoY)
EYE
EYE
+3.9% gap
EYE
7.9%
4.0%
ALC
Higher net margin
ALC
ALC
6.1% more per $
ALC
6.8%
0.7%
EYE

Income Statement — Q2 2025 vs Q3 2026

Metric
ALC
ALC
EYE
EYE
Revenue
$2.6B
$487.3M
Net Profit
$176.0M
$3.4M
Gross Margin
53.5%
Operating Margin
9.5%
2.0%
Net Margin
6.8%
0.7%
Revenue YoY
4.0%
7.9%
Net Profit YoY
-21.1%
139.8%
EPS (diluted)
$0.35
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALC
ALC
EYE
EYE
Q3 25
$487.3M
Q2 25
$2.6B
$486.4M
Q1 25
$510.3M
Q4 24
$437.3M
Q3 24
$451.5M
Q2 24
$2.5B
$451.7M
Q1 24
$482.8M
Q4 23
$421.0M
Net Profit
ALC
ALC
EYE
EYE
Q3 25
$3.4M
Q2 25
$176.0M
$8.7M
Q1 25
$14.2M
Q4 24
$-28.6M
Q3 24
$-8.5M
Q2 24
$223.0M
$-3.1M
Q1 24
$11.7M
Q4 23
$-16.0M
Gross Margin
ALC
ALC
EYE
EYE
Q3 25
Q2 25
53.5%
Q1 25
Q4 24
Q3 24
Q2 24
55.0%
Q1 24
Q4 23
Operating Margin
ALC
ALC
EYE
EYE
Q3 25
2.0%
Q2 25
9.5%
3.4%
Q1 25
5.1%
Q4 24
-5.8%
Q3 24
-2.0%
Q2 24
12.7%
0.1%
Q1 24
4.9%
Q4 23
-2.9%
Net Margin
ALC
ALC
EYE
EYE
Q3 25
0.7%
Q2 25
6.8%
1.8%
Q1 25
2.8%
Q4 24
-6.5%
Q3 24
-1.9%
Q2 24
8.9%
-0.7%
Q1 24
2.4%
Q4 23
-3.8%
EPS (diluted)
ALC
ALC
EYE
EYE
Q3 25
$0.04
Q2 25
$0.35
$0.11
Q1 25
$0.18
Q4 24
$-0.36
Q3 24
$-0.11
Q2 24
$0.45
$-0.04
Q1 24
$0.15
Q4 23
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALC
ALC
EYE
EYE
Cash + ST InvestmentsLiquidity on hand
$1.4B
$56.0M
Total DebtLower is stronger
$236.5M
Stockholders' EquityBook value
$22.1B
$858.8M
Total Assets
$31.4B
$2.0B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALC
ALC
EYE
EYE
Q3 25
$56.0M
Q2 25
$1.4B
$48.5M
Q1 25
$80.0M
Q4 24
$73.9M
Q3 24
$81.2M
Q2 24
$1.4B
$179.5M
Q1 24
$150.1M
Q4 23
$149.9M
Total Debt
ALC
ALC
EYE
EYE
Q3 25
$236.5M
Q2 25
$255.6M
Q1 25
$244.7M
Q4 24
$248.6M
Q3 24
$252.8M
Q2 24
$143.9M
Q1 24
$448.6M
Q4 23
$450.8M
Stockholders' Equity
ALC
ALC
EYE
EYE
Q3 25
$858.8M
Q2 25
$22.1B
$850.6M
Q1 25
$836.2M
Q4 24
$816.3M
Q3 24
$840.0M
Q2 24
$20.9B
$843.4M
Q1 24
$841.3M
Q4 23
$829.4M
Total Assets
ALC
ALC
EYE
EYE
Q3 25
$2.0B
Q2 25
$31.4B
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$29.7B
$2.1B
Q1 24
$2.2B
Q4 23
$2.2B
Debt / Equity
ALC
ALC
EYE
EYE
Q3 25
0.28×
Q2 25
0.30×
Q1 25
0.29×
Q4 24
0.30×
Q3 24
0.30×
Q2 24
0.17×
Q1 24
0.53×
Q4 23
0.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALC
ALC
EYE
EYE
Operating Cash FlowLast quarter
$46.6M
Free Cash FlowOCF − Capex
$30.3M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
13.83×
TTM Free Cash FlowTrailing 4 quarters
$83.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALC
ALC
EYE
EYE
Q3 25
$46.6M
Q2 25
$54.3M
Q1 25
$32.2M
Q4 24
$30.3M
Q3 24
$27.9M
Q2 24
$51.5M
Q1 24
$24.0M
Q4 23
$19.8M
Free Cash Flow
ALC
ALC
EYE
EYE
Q3 25
$30.3M
Q2 25
$42.4M
Q1 25
$12.0M
Q4 24
$-1.7M
Q3 24
$4.1M
Q2 24
$31.9M
Q1 24
$4.0M
Q4 23
$-13.0M
FCF Margin
ALC
ALC
EYE
EYE
Q3 25
6.2%
Q2 25
8.7%
Q1 25
2.4%
Q4 24
-0.4%
Q3 24
0.9%
Q2 24
7.1%
Q1 24
0.8%
Q4 23
-3.1%
Capex Intensity
ALC
ALC
EYE
EYE
Q3 25
3.4%
Q2 25
2.4%
Q1 25
4.0%
Q4 24
7.3%
Q3 24
5.3%
Q2 24
4.3%
Q1 24
4.1%
Q4 23
7.8%
Cash Conversion
ALC
ALC
EYE
EYE
Q3 25
13.83×
Q2 25
6.22×
Q1 25
2.27×
Q4 24
Q3 24
Q2 24
Q1 24
2.05×
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons